Page last updated: 2024-10-30

mesalamine and Sjogren's Syndrome

mesalamine has been researched along with Sjogren's Syndrome in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bar Yehuda, S1
Axlerod, R1
Toker, O1
Zigman, N1
Goren, I1
Mourad, V1
Lederman, N1
Cohen, N1
Matz, E1
Dushnitzky, D1
Gavish, M1
Borovsky, N1
Schwarts, D1
Dotan, I1
Turner, D1
Qanneta, R1
García Pardo, G1
Florit Serra, L1

Other Studies

2 other studies available for mesalamine and Sjogren's Syndrome

ArticleYear
The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
    Journal of Crohn's & colitis, 2019, Mar-26, Volume: 13, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biological Products; Case

2019
Acute pleuropericarditis in a patient with primary Sjögren's syndrome and quiescent ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Mesalamine; Middle Age

2013